Slope, a San Francisco, CA-based clinical operations solution company, closed a $20m Series A financing.
The round was led by New Enterprise Associates.
The company intends to use the funds to accelerate go-to-market efforts and further expand into decentralized and direct-to-patient clinical trials.
Led by Rust Felix, CEO and co-founder, Slope provides a technology-driven infrastructure solution that connects all clinical trial stakeholders—ClinOps teams, CROs, research sites, patients, vendors, and laboratories—in real-time through a 21 CFR Part 11 compliant software platform, capturing clinical supply chain demand data at the patient level and then using it alongside research-specific workflows to orchestrate and automate operational complexity.
Slope launched its free inventory management solution for clinical research sites in 2018. Today, it has over 4,500 users across 660 clinical research sites using the platform. In 2019, the company released its solution for clinical trial sponsors and CROs that connects Clinical Operations teams to the wealth of operational data that occurs at the patient level. In 2021, Slope opened a fulfillment center in Richmond, Virginia, manufacturing smart lab kits that enable real-time inventory management, automated lab kit resupply, sample collection workflows, intelligent sample-to-lab routing, with an electronic audit trail that provides full traceable chain of custody across all activities and stakeholders.
To date, Slope has managed chain of custody for tens of thousands of clinical trial samples and is rapidly expanding the use of their technology to facilitate clinical supply chain visibility and automation for both decentralized and direct-to-patient clinical trials.
FinSMEs
06/10/2021